28.5 C
New York
Thursday, June 18, 2026

Tag: collaborations

newssourceFORcompanyinformationcontent1marketreleases

The World’s First “Superfluidized Inorganic Solid-State Electrolyte” Paves the Way for Full-Scale Commercialization of Next-Generation Solid-State Lithium Batteries

ProLogium today unveiled its groundbreaking fourth-generation innovation—the Superfluidized Inorganic Solid-State Electrolyte

Access Unparalleled: Premier Hosted Buyers Converge on Global Beverage & Tea Trends 2025

SHANGHAI, July 30, 2025 /PRNewswire/ -- The 28th edition of FHC Shanghai Global Food Trade Show will return to the Shanghai New International Expo Centre...

Dr. Falk Pharma and Allianthera (Suzhou) Biopharmaceuticals Forge Strategic Partnership for Novel AhR Agonist Development

Freiburg (Germany), Suzhou (China) and Boston (USA), July 30, 2025: 

Photocure ASA: Results for the second quarter of 2025

OSLO, Norway, July 30, 2025 /PRNewswire/ -- Photocure ASA (OSE: PHO) today reported Hexvix®/Cysview® revenues of NOK 135.6 million in the second quarter of 2025...

Photocure ASA: Results for the second quarter of 2025

OSLO, Norway, July 30, 2025 /PRNewswire/ -- Photocure ASA (OSE: PHO) today reported Hexvix®/Cysview® revenues of NOK 135.6 million in the second quarter of 2025...

Meet the Finalists: TWOPAGES X Design Contest Public Vote Now Live

A 10th Anniversary Design Tribute, TWOPAGES Ushers in a New Chapter of Global Co-Creation 
A 10th Anniversary Design Tribute, TWOPAGES Ushers in a New Chapter of Global Co-Creation

Harbour BioMed to Present Phase II Data of HBM4003 and Tislelizumab Combination in MSS Metastatic Colorectal Cancer at ESMO 2025

CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, July 29, 2025 /PRNewswire/ -- Harbour BioMed (HKEX: 02142), a global biopharmaceutical company focused on the discovery and development...

SANY Scales Up Green Energy Footprint in Africa with Breakthrough Solar Projects

SHANGHAI, July 29, 2025 /PRNewswire/ -- At the end of June, SANY officially commenced construction of a 10MW photovoltaic power plant in Zimbabwe. The project,...

Giants Protocol Powers Tokenization of Real Estate for The Assembly Place, Backed by Singapore’s Sovereign Wealth Fund

SINGAPORE, July 29, 2025 (GLOBE NEWSWIRE) -- Giants Protocol, a pioneer in AI-powered real-world asset (RWA) tokenization, has announced a landmark collaboration with Singapore-based co-living operator The Assembly Place (TAP) to tokenize real estate assets. This strategic move showcases the protocol’s ability to transform physical infrastructure into on-chain, yield-generating opportunities. The announcement marks a key milestone in Giants’ journey, having been backed by Singapore’s Sovereign Wealth Fund since inception and now delivering tangible use cases in Asia’s fast-evolving tokenization landscape.

MetrioPharm’s MP1032 Receives EMA Orphan Drug Designation in Duchenne Muscular Dystrophy

Zurich, July 29, 2025 – MetrioPharm AG, a pharmaceutical company developing drugs for inflammatory and infectious diseases, announced today that the European Medicines Agency has granted Orphan Drug Designation (ODD) to its lead compound, MP1032 for the treatment of children affected by Duchenne muscular dystrophy (DMD). This milestone follows the U.S. FDA's ODD, underscoring MP1032's potential as a first-in-class therapy that could minimize reliance on high-dose corticosteroids, which cause severe side effects like osteoporosis, growth stunting, and metabolic issues.

Alpha-synuclein Inhibitors Market to Witness Strong CAGR Through 2034, Driven by Advances in Neurodegenerative Therapies | DelveInsight

No alpha-synuclein inhibitors are approved, underscoring a major need for therapies that slow or halt Parkinson's progression. Developing safe, brain-penetrant drugs that target toxic...

In Celebration of Tony Bennett’s Birthday, CARNEGIE HALL+ Announces the Streaming Premiere of BECAUSE OF YOU, Michael Feinstein’s Concert Tribute to Tony Bennett, Beginning...

Special streaming premiere of performance featuring the Carnegie Hall Big Band, filmed on tour at Segerstrom Center for the Arts, available for the first...

Biologic Therapeutics Market to Hit $794.5 Billion by 2029

"Driven by Rising Chronic Disease Burden and Breakthrough FDA Approvals, Biopharmaceutical Market Surges with Demand for Monoclonal Antibodies, Gene and Cell Therapies, and Innovative...

Biologic Therapeutics Market to Hit $794.5 Billion by 2029

"Driven by Rising Chronic Disease Burden and Breakthrough FDA Approvals, Biopharmaceutical Market Surges with Demand for Monoclonal Antibodies, Gene and Cell Therapies, and Innovative...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsCollaborations

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers